Varnitrip
Varnitrip

2.42
A generic medicine indicated for addiction and withdrawal. Targets nicotine receptors in the brain to reduce cravings and decrease the satisfaction derived from continued use.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Varenicline
Reference Brand
Varenicline
Product Origin
Generic Brand
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Vitamins & Supplements
Product Category
Partial Nicotinic Acetylcholine Receptor Agonist
Pharmacological Class
Smoking Cessation Agent
Clinical Indications
Manufacturer Description
Utilized to manage nicotine addiction to alleviate physical cravings and support long-term smoking cessation.
Mechanism of Action
Binds selectively to neuronal alpha-4-beta-2 nicotinic receptors, exerting partial agonist effects to block nicotine reward mechanisms.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
History of severe psychiatric disorders, Severe renal impairment
Severe Adverse Events
Severe depression and suicidal ideation — requires immediate medical attention, Seizure activation — requires immediate medical attention
Common Side Effects
Nausea, Headache, Insomnia
Uncommon Side Effects
Vivid dreams, Flatulence, Fatigue
Drug Interactions
Alcohol
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.
Age Restrictions
Approved for adults over eighteen years.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Varnitrip is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to order Antidepressant Tablets - Buy Trintellix AU